Commit To Buy Taysha Gene Therapies At $2.50, Earn 16.8% Annualized Using Options

Commit To Buy Taysha Gene Therapies At .50, Earn 16.8% Annualized Using Options


Investors eyeing a purchase of Taysha Gene Therapies Inc (Symbol: TSHA) shares, but tentative about paying the going market price of $4.61/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $2.50 strike, which has a bid at the time of this writing of 35 cents. Collecting that bid as the premium represents a 14% return against the $2.50 commitment, or a 16.8% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

Selling a put does not give an investor access to TSHA’s upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $2.50 strike if doing so produced a better outcome than selling at the going market price. (Do options carry counterparty risk? This and six other common options myths debunked). So unless Taysha Gene Therapies Inc sees its shares decline 45.5% and the contract is exercised (resulting in a cost basis of $2.15 per share before broker commissions, subtracting the 35 cents from $2.50), the only upside to the put seller is from collecting that premium for the 16.8% annualized rate of return.

Below is a chart showing the trailing twelve month trading history for Taysha Gene Therapies Inc, and highlighting in green where the $2.50 strike is located relative to that history:

Loading+chart+—+2026+TickerTech.com

The chart above, and the stock’s historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the December put at the $2.50 strike for the 16.8% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Taysha Gene Therapies Inc (considering the last 250 trading day closing values as well as today’s price of $4.61) to be 93%. For other put options contract ideas at the various different available expirations, visit the TSHA Stock Options page of StockOptionsChannel.com.

Top YieldBoost Puts of the S&P 500 »

Also see:

• Funds Holding XINC
• ETFs Holding BSTC
• PDVW Insider Buying

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



Source link


Discover more from stock updates now

Subscribe to get the latest posts sent to your email.

Leave a Reply

SleepLean – Improve Sleep & Support Healthy Weight